Lynx1 Capital Management LP TCRX Holdings History
Lynx1 Capital Management LP's TScan Therapeutics Inc Holding Summary
As of 2025-03-31, Lynx1 Capital Management LP held 5.36 Mil shares of TScan Therapeutics Inc(TCRX), totaling $7.39 Mil. This investment constitutes 2.65% of their stock portfolio, and Lynx1 Capital Management LP now holds 9.47% of the outstanding TScan Therapeutics Inc(TCRX) stock.
The initial trade took place in 2023Q2. And since then Lynx1 Capital Management LP has made 3 purchases of TCRX, at an average price of $2.22, for a total of 7.95 Mil shares. Based on historical transaction data and TCRX's current price of $1.86, Lynx1 Capital Management LP's estimated gain on his TCRX holdings is $-2.88 Mil, reflecting a -16.30% gain to date.
Lynx1 Capital Management LP TCRX ($1.86) Holding Chart
Lynx1 Capital Management LP TCRX ($1.86) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
